Quantitative measurement of acute myocardial infarction cardiac biomarkers by "All-in-One" immune microfluidic chip for early diagnosis of myocardial infarction

Spectrochim Acta A Mol Biomol Spectrosc. 2024 Jul 5:315:124256. doi: 10.1016/j.saa.2024.124256. Epub 2024 Apr 10.

Abstract

Acute myocardial infarction (AMI) is a life-threatening condition with a narrow treatment window, necessitating rapid and accurate diagnostic methods. We present an "all-in-one" convenient and rapid immunoassay system that combines microfluidic technology with a colloidal gold immunoassay. A degassing-driven chip replaces a bulky external pump, resulting in a user-friendly and easy-to-operate immunoassay system. The chip comprises four units: an inlet reservoir, an immunoreaction channel, a waste pool, and an immunocomplex collection chamber, allowing single-channel flow for rapid and accurate AMI biomarker detection. In this study, we focused on cardiac troponin I (cTnI). With a minimal sample of just 4 μL and a total detection time of under 3 min, the chip enabled a quantitative visual analysis of cTnI concentration within a range of 0.5 ∼ 60.0 ng mL-1. This all-in-one integrated microfluidic chip with colloidal gold immunoassay offers a promising solution for rapid AMI diagnosis. The system's portability, small sample requirement, and quantitative visual detection capabilities make it a valuable tool for AMI diagnostics.

Keywords: AMI cardiac biomarkers Myocardial infarction; All-in-One; Immune microfluidic chip; Quantitative analysis.

Publication types

  • Review

MeSH terms

  • Biomarkers* / analysis
  • Biomarkers* / blood
  • Early Diagnosis*
  • Gold Colloid / chemistry
  • Humans
  • Immunoassay / instrumentation
  • Immunoassay / methods
  • Lab-On-A-Chip Devices*
  • Microfluidic Analytical Techniques / instrumentation
  • Microfluidic Analytical Techniques / methods
  • Myocardial Infarction* / diagnosis
  • Troponin I* / analysis
  • Troponin I* / blood

Substances

  • Biomarkers
  • Troponin I
  • Gold Colloid